This inventor holds 1 USPTO granted patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: DaeKyu Choi: Inventor of a GPR119 Agonist Patent.
Introduction
DaeKyu Choi is an inventor based in Yongin, South Korea. His patent work includes pharmaceutical research focused on amide derivatives that act as GPR119 agonists.
Latest Patents
Choi is associated with 1 patent, titled “Amide Derivatives for GPR119 Agonist.” The invention concerns novel amide derivatives, their stereoisomers, and pharmaceutically acceptable salts, as well as methods for preparing them and pharmaceutical compositions containing them. The compounds are described as GPR119 agonists with potential use in treating metabolic disorders, including type II diabetes and related conditions.
Career Highlights
Choi is associated with Chong Kun Dang Pharmaceutical Corporation, a pharmaceutical company. His patent reflects work on potential therapeutic compounds for metabolic disorders.
Collaborations
The patent lists Yuntae Kim and ChangSik Lee among Choi’s coworkers, indicating collaboration in the development of the invention.
Conclusion
DaeKyu Choi’s patent work at Chong Kun Dang Pharmaceutical Corporation centers on amide derivatives with potential applications in treating type II diabetes and related metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile